Join PER® September 15th for the New York Advanced Practice Collaborative Meeting! Directed toward NP/PAs, this meeting blends presentations on cutting-edge information with panel discussions to enhance learning.

Drug Label Overload

Tuesday, May 31, 2011
Prescription drug labels serve as a source of information for healthcare providers as well as consumers. Researchers from Indiana University School of Medicine in Indianapolis, Indiana recently reviewed the adverse drug warnings on the labels of 5,000 prescription drugs. The number of adverse drug event warnings ranged from 0 to 525 per label (mean = 70).

More warnings, on average, appeared on the labels of the 200 most commonly prescribed drugs, and newer medications (those approved in the past decade) had significantly higher numbers of adverse events per label than older drugs. The researchers noted that the large amount of adverse drug warning information, which they referred to as “over-warning,” could result in information overload.

I have to agree; a large amount of adverse drug warning information on drug labels may actually be harmful rather than helpful. Busy clinicians do not have the time, nor the patience, to sort through dozens of potential adverse events that appear on drug labels. Every reported event appears on drug labels, and I often wonder if the drug caused or contributed to some of the reported adverse events, or if they were coincidental occurrences. In addition, we need to be knowledgeable about drug interactions since most of our patients are taking two or more prescription drugs. Fortunately there are several online tools that identify potential drug interactions; just type “drug interaction checker” into a search engine to see multiple options for checking for drug interactions.


Duke J, et al "A quantitative analysis of adverse events and 'overwarning' in drug labeling" Arch Intern Med 2011; 171 (10): 944-946. Arch Intern Med

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN
Blog Info
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN is an oncology nursing consultant and editor-in-chief of Oncology Nursing News.
Author Bio
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN, is the Editor-in-Chief for OncLive Nursing. She is an oncology nursing consultant and adjunct assistant professor of nursing at Louisiana State Health Sciences Center in New Orleans, LA. She provides continuing nursing education to nurses across the Unites States, is active in several professional nursing organizations, and is intrigued by the many ways nurses use technology to communicate.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.